Comment on: Association between the beta‐blockers, calcium channel blockers, all‐cause mortality, and length of hospitalization in patients with heart failure with preserved ejection fraction: A meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Comment on: Association between the beta‐blockers, calcium channel blockers, all‐cause mortality, and length of hospitalization in patients with heart failure with preserved ejection fraction: A meta‐analysis of randomized controlled trials

Published:2023-09-19 Issue:1 Volume:47 Page:
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clinical Cardiology

Author:

Zakiev Vadim¹^ORCID,Gvozdeva Anna²^ORCID,Skotnikov Anton³^ORCID

Affiliation:

1. Russian Clinical and Research Center of Gerontology Pirogov Russian National Research Medical University Moscow Russia

2. Chazov National Medical Research Center of Cardiology Myasnikov Institute of Clinical Cardiology Moscow Russia

3. Department of Medical and Social Assessment, Emergency, and Ambulatory Practice Sechenov First Moscow State Medical University Moscow Russia

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.24125

Reference9 articles.

1. WuM NiD HuangL QiuS.Association between the beta‐blockers calcium channel blockers all‐cause mortality and length of hospitalization in patients with heart failure with preserved ejection fraction: a meta‐analysis of randomized controlled trials.Clin Cardiol. Published online June 4 2023.doi:10.1002/clc.24058

2. Mortality and morbidity of newly diagnosed heart failure with preserved systolic function treated with β-blockers: A propensity-adjusted case–control populational study

3. Beta-blockers in older patients with heart failure and preserved ejection fraction: Class, dosage, and outcomes

4. The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: A meta-analysis of observational cohort and randomized controlled studies

5. Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction